Heat Shock Protein 90AB3P: Potential Drug Target and Cellular Processes

Target Name: HSP90AB3P

NCBI ID: G3327

HSP90AB3P

Other Name(s): Heat shock protein 90 alpha family class B member 3, pseudogene | heat shock protein 90 alpha family class B member 3, pseudogene | HSP90BC | HSPCP1

Heat Shock Protein 90AB3P: Potential Drug Target and Cellular Processes

Heat shock protein 90 alpha family class B member 3 (HSP90AB3P) is a protein that is expressed in various cell types, including muscle, heart, brain, and kidney. It is a member of the HSP90伪 family, which is a well-known family of proteins that are involved in various cellular processes, including stress response, cytoskeletal organization, and signaling pathways. HSP90AB3P is a pseudogene, which means that it is a genetic copy of a protein that does not have a functional gene.

HSP90AB3P is involved in various cellular processes that are critical for cell survival and function. One of its functions is to regulate the formation of stress granules, which are organelles that are involved in the production of reactive oxygen species (ROS) during stress. During stress, cells produce ROS, which can damage cellular components and contribute to various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. HSP90AB3P is involved in regulating the formation of stress granules by interacting with the protein heat shock factor (HSP70), which is a protein that is also involved in stress response.

Another function of HSP90AB3P is to regulate the cytoskeleton. cytoskeleton is the protein structure that organizes the cytoplasm in cells, and it plays a critical role in cell stability, movement, and division. HSP90AB3P is involved in regulating the cytoskeleton by interacting with the protein microtubule dynamics protein (MTD), which is involved in the regulation of cytoskeletal organization.

HSP90AB3P is also involved in cell signaling pathways. During signaling pathways, proteins interact with other proteins to transmit signals from one cell to another. HSP90AB3P is involved in several signaling pathways, including the regulation of cell proliferation, the development and progression of cancer, and the regulation of inflammation.

HSP90AB3P is also a potential drug target. Its involvement in various cellular processes makes it an attractive target for the development of new therapeutic agents. For example, HSP90AB3P has been shown to be involved in the regulation of stress granule formation, which could make it an attractive target for stress-induced diseases, such as cancer, neurodegenerative diseases, and cardiovascular diseases. Additionally, HSP90AB3P's involvement in the regulation of cytoskeletal organization makes it an attractive target for diseases that are characterized by disruptions in cytoskeletal structure, such as muscle wasting diseases.

In conclusion, HSP90AB3P is a protein that is involved in various cellular processes that are critical for cell survival and function. Its involvement in stress response, cytoskeletal organization, and signaling pathways makes it an attractive target for the development of new therapeutic agents. Further research is needed to fully understand the role of HSP90AB3P in various cellular processes and its potential as a drug target.

Protein Name: Heat Shock Protein 90 Alpha Family Class B Member 3, Pseudogene

Functions: Putative molecular chaperone that may promote the maturation, structural maintenance and proper regulation of specific target proteins

The "HSP90AB3P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HSP90AB3P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets